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Abstract
The regulation of the acid-base balance in cells is essential for proper cellular homeostasis. Disturbed acid-base balance
directly affects cellular physiology, which often results in various pathological conditions. In every living organism, the
protein family of carbonic anhydrases regulate a broad variety of homeostatic processes. Here we describe the
identification, mapping and cloning of a zebrafish carbonic anhydrase 5 (ca5) mutation, collapse of fins (cof), which causes
initially a collapse of the medial fins followed by necrosis and rapid degeneration of the embryo. These phenotypical
characteristics can be mimicked in wild-type embryos by acetazolamide treatment, suggesting that CA5 activity in zebrafish
is essential for a proper development. In addition we show that CA5 regulates acid-base balance during embryonic
development, since lowering the pH can compensate for the loss of CA5 activity. Identification of selective modulators of
CA5 activity could have a major impact on the development of new therapeutics involved in the treatment of a variety of
disorders.
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Introduction
Maintaining proper homeostasis is essential for every living
organism. Homeostatic imbalance directly affects cellular metab-
olism, which eventually leads to physiological defects and
pathologic conditions. Carbonic anhydrases (CA) are zinc
metalloenzymes that are present in prokaryotes and eukaryotes.
They catalyze the reversible dehydration/hydration reaction of
carbon dioxide (CO2 + H2O « HCO3
2+ H
+) [1,2]. CAs are
involved in many physiological processes such as transport of
carbon dioxide and bicarbonate between tissues, acid-base balance
and biosynthetic reactions (glucogenesis, lipogenesis and ureagen-
esis) [3]. CAs are also important therapeutic targets, because of
their involvement in various pathological conditions, such as
glaucoma, obesity, some infectious diseases, cancer, epilepsy and
osteoporosis [4] Therefore, many CA inhibitors and activators
have been developed in order to treat these disorders [4]. Of the
five different classes of CAs (a-eCA), vertebrates only express
proteins of the a-CA class, which comprises 16 members that
differ in their kinetic properties, tissue distribution, subcellular
localization and their susceptibility to inhibitors [2,4–12]. Whereas
most CA isoforms are localized in the cytosol or associate with the
plasma membrane, carbonic anhydrase 5 (CA5) is the only
mitochondrial a-CA [13]. In mammals CA5 is encoded by two
genes, CA5A and CA5B and whereas CA5A is expressed only in the
liver, CA5B is widely expressed in many tissues [14]. Here we
describe the mapping, cloning and characterization of a ca5
mutant zebrafish (collapse of fins, cof) and show that CA5 is involved
in regulating acid-base balance during embryonic development in
zebrafish.
Methods
Zebrafish strains and Forward genetic screening
Adult fish were raised and maintained under standard
laboratory conditions. Fish experiments were performed in
accordance with institutional guidelines and as approved by the
Animal Experimentation Committee of the Royal Netherlands
Academy of Arts and Sciences. The cof mutant was identified
during a forward genetic screen performed at the Hubrecht
Institute, Utrecht, The Netherlands. N-Ethyl-N-nitroso-ureum
(ENU) mutagenesis was performed as previously described for the
creation of the Hubrecht Institute target selected mutagenesis
library [15]. F1 progeny of mutagenised male fish were outcrossed
to wild-type fish in order to produce approximately 300 F2
families, which were then intercrossed. F3 progeny were screened
for epidermal integrity defects at 2–3 dpf. Meiotic mapping of the
collapse of fins mutation was performed using standard simple
sequence length polymorphisms (SSLP). SSLP primer sequences
can be found on www.ensembl.org. Genotyping PCR and
subsequent sequencing of the ca5
T839A mutation on finclip DNA
or DNA of single embryos was performed with the following
primers: F: 5 -cggacagcaagacatctg-39 and R: 59-ttgtggatacacatccc-
catag-39.
Zebrafish embryo culturing
Embryos were raised in egg medium (60 mg/ml sea salt) pH 7.
After 24 hpf dechorionated embryos were collected and placed in
agarose-coated culture dishes with egg medium or 1x Danieau’s
medium (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM
Ca [NO3]2 buffered at different pH with 10 mM Hepes.
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39881Acetazolamide treatment
Acetazolamide (Sigma) was dissolved in DMSO to a concentra-
tion of 0.5 M and diluted to a working concentration of 2.5 mM
and 5 mM in egg- or Danieau’s medium. Control embryos were
treated with the same amount of DMSO solvent.
In situ hybridisation, cDNA constructs and RNA synthesis
Whole mount in situ hybridization (ISH) was performed as
described previously [16]. Embryos for ISH were fixed with 4%
PFA/PBS and stored in 100% methanol. After ISH, embryos were
cleared in methanol and mounted in benzylbenzoate/benzylalco-
hol (2:1) before images were taken. The following primers were
used to produce the ca5 cDNA fragment: F: 59-tgcatccaatgtggcag-
gag-39;R :5 9-ttgtgtctgactgcaggcaagg-39 and the insulin cDNA
fragment: F: 59-ttggtcgtgtccagtgtaag-39;R :5 9-tgcctctcttccttatcagc-
39. Fragments were cloned into the pCRII-TOPO vector
(Invitrogen) and antisense dig-labelled probes were synthesised
according to standard protocols. Full-length zebrafish ca5 cDNA
(MGC:171653; IMAGE:7448163) was derived by PCR on cDNA
with the primers: F: 59-gcgaattcaccatggtcacactgacagccat-39 and R:
59-gcctcgagttattccttagaggggg-39 and cloned into the pCS2+ vector
with EcoR1/Xho1. RNA was synthesised in vitro by using the
SP6 mMessage mMachine kit (Ambion). The ca5
T839A mutation
was introduced using the QuickChange kit (Stratagene).
Figure 1. Characterization, mapping and cloning of the cof mutant. (A–D) Phenotypical comparison of wild-type and cof mutant embryos at
2 dpf (A, B) and 3 dpf (C, D). Asterisks mark the collapse of the medial fins in the cof mutant. (E) Summary of the linkage analysis and mapping of the
cof locus at chromosome 25. The arrows mark the direction of the mutation. Red lines indicate the various transcripts in the genomic region. (F)
Sequence chromatograms of wild-type and cof mutant cDNA. The corresponding amino acid residues are indicated below. (G) CA5 protein sequence
alignment of zebrafish and human and other members of the human CA protein family. Arrow marks residue M280 that is substituted to a lysine in
cof mutant embryos. (H) Detection of ca5 mRNA in wild-type embryos at 24, 48 and 72 hpf by in situ hybridization. mRNA expression of insulin at 24
hpf marks the position of pancreatic b-cells. Upper panel shows dorsal view and lower panels lateral view. White arrowheads mark the expression in
the lens and the pancreatic b-cells.
doi:10.1371/journal.pone.0039881.g001
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A missense mutation in zebrafish carbonic anhydrase 5
leads to collapse of the medial fins, heart failure and
rapid degeneration of the zebrafish embryo
From a forward genetic screen in zebrafish we derived a mutant
allele, collapse of fins (cof) that is characterized by defects of
epidermal integrity and collapse of the medial fins at 2 days post-
fertilization (dpf) (Figure 1A, B). During later stages of de-
velopment, cardiac failure with edema and necrosis of the yolk-sac
can be observed (Figure 1C, D), eventually leading to the rapid
degeneration of the complete embryo at 4 dpf. The cof mutant
phenotype is not fully penetrant, only 19% (instead of 25%) of the
embryos can be phenotypically identified as a mutant in a batch of
cof embryos (see Table 1). Meiotic mapping placed the cof allele on
chromosome 25 between markers G39307 and z68140 (Figure 1E).
Sequencing the open reading frames of the genes within the
corresponding genomic interval revealed a T839A mutation in the
coding region of the ca5 gene (Figure 1F). ca5 encodes for the
zebrafish orthologue of CA5. The ca5
T839A mutation results in an
amino acid substitution of residue M280 to a lysine (Figure 1F).
CA5 protein comparison analyses show that M280 is highly
conserved across species and other members of the CA protein
family (Figure 1G). The zebrafish genome contains only one ca5
gene and comparison of the amino acid sequences reveals 31%
identity between zfCA5 and huCA5A, and 40% between zfCA5
and huCA5B. In order to study the ca5 mRNA expression, whole
mount in situ hybridization was performed on wild-type embryos at
various stages of development. This revealed ca5 mRNA
expression in the lens and in a specific part of the embryo that
resembles the developing pancreas at 24 hpf (Figure 1H). Previous
studies have identified human CA5B in the insulin-producing b-
cells of the pancreas [17]. To verify the mRNA expression of ca5 in
the pancreatic b-cells in zebrafish, we compared ca5 expression
with the expression of insulin, a marker for the pancreatic b-cells at
24 hpf. Indeed ca5 mRNA is localized at the same position as the
insulin expressing cells (Figure 1H). During later stages of
development, ca5 remains expressed in the pancreas (Figure 1H).
The expression of insulin mRNA in the ca5
cof mutants was
indistinguishable from that in wild-type embryos (Figure 1H),
suggesting that b-cell development is not impaired in ca5
cof mutants
during development. This was confirmed by determining the level
of insulin mRNA expression by PCR on cDNA of wild-type sibling
and ca5
cof mutant embryos at 60 hpf (Figure 1H). Although we
observed a clear morphological defect in the medial fins of the
ca5
cof mutants, ca5 expression could not be detected in the fin
epidermis by in situ hybridisation.
Expression of CA5 rescues the ca5
cof mutant phenotype
and acetazolamide treatment in wild-type embryos
phenocopies the ca5
cof mutation
To examine whether the ca5
T839A mutation in ca5
cof mutant
embryos causes the ca5
cof mutant phenotype, we restored CA5
expression by injecting the full-length zebrafish ca5 RNA. Injecting
100 pg ca5 RNA rescued the ca5
cof mutant phenotype completely,
whereas it was not rescued after the injection of 100 pg mutant
ca5
T839A RNA (Figure 2A-F and Table 1).
In order to determine whether the ca5
M280K substitution results
in a reduced enzymatic activity of the CA5 protein we treated
dechorionated wild-type embryos at 24 hpf with acetazolamide
(AZA), a general CA inhibitor. Treatment with 5 mM AZA
generated essentially a phenocopy of the ca5
cof mutant fish
including collapse of the medial fins, cardiac failure and necrosis
of the yolk (Figure 2I-L and Table 1), ultimately leading to
degeneration of the embryo. We verified the capacity of AZA to
inhibit CA5 enzymatic activity by performing synergistic in-
teraction experiments in ca5
cof heterozygous sibling embryos. We
treated wild-type embryos and a batch of cof embryos with
suboptimal concentrations of AZA. The morphology of wild-type
embryos treated with 2.5 mM AZA was not altered (Figure 2M, N
and Table 1), however in the cof batch of embryos around 66% of
the embryos showed the ca5
cof mutant phenotype (Table 1).
Sequencing revealed that a suboptimal dosage of AZA could
induce the cof mutant phenotype in heterozygous embryos
Table 1. Quantification of the injection experiments and the various treatments.
Phenotype (at 3 dpf) % wild-type % cof mutant
cof batch of embryos (n=65) 81 19
100 pg full-length ca5 RNA (n=98) 99 1
100 pg ca5
T839A RNA (n=59) 83 17
untreated wild-type embryos (n=81) 100 0
wild-type embryos treated with 5 mM AZA (n=73) 10 90
wild-type embryos treated with 2.5 mM AZA (n=65) 99 1
cof batch of embryos treated with 2.5 mM AZA (n=58) 34 66
wild-type embryos raised at pH 5 (n=67) 100 0
wild-type embryos raised at pH 7.6 (n=67) 100 0
wild-type embryos raised at pH 10 (n=67) 100 0
wild-type embryos +5mM AZA in pH 5 medium (n=75) 77 23
wild-type embryos +5mM AZA in pH 7.6 medium (n=84) 16 84
wild-type embryos +5mM AZA in pH 10 medium (n=76) 4 96
cof batch of embryos in pH 5 medium (n=81) 98 2
cof batch of embryos in pH 7.6 medium (n=77) 82 18
cof batch of embryos in pH 10 medium (n=68) 76 24
doi:10.1371/journal.pone.0039881.t001
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sibling embryos were not affected. All this shows that inhibition of
CA5 activity by AZA treatment during embryonic development
can mimic the ca5
cof mutant phenotype. Thus the ca5
T839A
missense mutation results in a severe reduction or loss of CA5
activity that initially leads to a collapse of the medial fins, followed
by complete degeneration of the embryo.
Low pH reduces the effects of acetazolamide treatment
in wild-type embryos and rescues the ca5
cof mutant
phenotype
Carbonic anhydrases are also involved in the regulation of acid-
base balance, also in fish [18]. Therefore we examined the effect of
altered pH levels on the collapse of the medial fins in AZA-treated
wild-type embryos and ca5
cof mutant embryos. First, wild-type
embryos were raised from 24 hpf onwards in Danieau’s medium of
pH 5, pH 7.6 or pH 10, containing 5 mM AZA. These experi-
ments show that wild-type embryos are less susceptible to AZA,
when cultured in pH 5 medium, compared to embryos cultured in
pH 7.6 or pH 10 medium (Figure 3A-L). Furthermore, the ca5
cof
mutant phenotype can be rescued by raising mutant embryos in
Danieau’s medium of pH 5 (see Table1), suggesting that normally
the increase in cellular pH during embryonic development is
compensated by the activity of mitochondrial CA5 (Table 1). We
could not observe any significant developmental defects when
wild-type embryos were raised in medium of pH 5 or pH 10
(Table 1). All this shows that CA5 is involved in maintaining
cellular acid-base balance during zebrafish embryonic develop-
ment.
Discussion
We show that defective CA5 activity in zebrafish results in
a disturbed cellular acid-base balance, which leads to the collapse
of the medial fins, heart failure and eventually degeneration of the
complete embryo. We show that AZA, a general CA inhibitor, can
copy the phenotype caused by the ca5
cof mutation in wild-type
embryos, suggesting that the T839A mutation results in the loss of
CA5 enzymatic activity.
Human mitochondrial CA5 activity has been shown to be
markedly elevated when the pH increases [19]. Thus loss or
a reduced of CA5 activity results in an increase in cellular pH,
which eventually leads to defects in cellular homeostasis. This is in
Figure 2. Rescue of the ca5
cof mutant and acetazolamide
treatment phenocopies the cof mutation in wild-type embryos.
(A, B) ca5
cof mutant embryos, (C–F) ca5
cof mutant embryos injected with
100 pg full-length wild-type ca5 (C, D) or 100 pg ca5
T839A mutant RNA
(E, F). (I–L) Wild-type embryos at 2 dpf (I–K) and 3 dpf (L) treated with
5 mM AZA. Treatment of wild-type and cof heterozygous embryos at 2
dpf with 2.5 mM AZA.
doi:10.1371/journal.pone.0039881.g002
Figure 3. Low pH compensates for loss of carbonic anhydrase
activity by acetazolamide treatment. (A–C) Untreated wild-type
embryos, (D–L) wild-type embryos at 3 dpf treated in pH 5 (D–F), pH 7.6
(G–I), or pH 10 medium (J–L) with 5 mM AZA.
doi:10.1371/journal.pone.0039881.g003
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the pH of the embryo medium can compensate for the loss of CA5
activity. In addition, the cof mutation is not fully penetrant when
cultured in egg medium of pH 7 (,19%), however an increase of
the pH (pH 10) of the medium resulted in full penetrance of the
mutation (,24%) (Table 1), again showing that regulating acid-
base balance is the major function of CA5 during zebrafish
development.
Although the initial phenotypical defect is observed in the
medial fins, ca5 mRNA expression could only be detected in the
pancreatic b-cells at 2 and 3 dpf. Defective CA5 function in the
pancreatic b-cells cannot explain the medial fin defects and the
rapid degeneration of ca5
cof mutants. First of all, the level of insulin
mRNA in the mutant embryos is not altered, suggesting that b-cell
development is not impaired in ca5
cof mutants. In addition,
zebrafish mutants that lack pancreatic b-cells do not develop the
phenotypical characteristics that we observe in the ca5
cof mutant
[20]. A plausible explanation for the severe medial fin defect and
the rapid degeneration of the ca5
cof mutant would be that CA5 is
expressed at low levels in the epidermis. The defective epidermal
acid-base balance, severely affects the epidermal barrier function,
which results in rapid necrosis and degeneration of the embryo,
especially in an aquatic environment. In fish several of the CA
isoforms have been implicated in regulating physiological pro-
cesses of the skin. For example, in a subtype of ionocytes of the
skin and gills cytoplasmic CA regulates ionic exchange and acid-
base balance [21]. However, knockdown of these cytoplasmic CA
isoforms did not result in obvious morphological defects [21]. Here
we observe a rapid degeneration of the complete embryo upon
defective CA5 function, revealing that CA5 fulfils a major role in
the regulation of cellular epidermal homeostasis, during de-
velopment in zebrafish.
Although we did not see any effect on pancreatic b-cell
development, we cannot rule out that defective CA5 function
affects insulin secretion or could affect pancreatic b-cell de-
velopment during later stages of development. Human CA5B is
expressed in pancreatic b-cells and has been shown to provide
bicarbonate for the first step of gluconeogenesis. It is therefore
implicated in insulin secretion [17,22]. Furthermore, inhibition of
CA activity with AZA resulted in a strong inhibition of glucose-
stimulated insulin secretion [17]. In the light of our findings,
inhibition of insulin secretion in pancreatic b-cells after AZA
treatment could be a secondary effect: defective acid-base balance
causes impaired cellular homeostasis which leads to impaired
insulin secretion.
Because CA5 is the only mitochondrial CA, it is an excellent
pharmaceutical target. Currently many CA inhibitors and
activators have been developed in order to treat a range of
disorders [4]. Some of these compounds have been shown to
inhibit or activate also the mitochondrial CA5 and are used in the
clinic as anti-obesity or anti-epileptic drug [23–26]. However,
pharmacological inhibitors that are selective for CA5 are currently
not available.
In conclusion, in this study we report the identification of the
first vertebrate in vivo model in which defective CA5 activity results
in imbalanced cellular acid-base homeostasis. The fact that AZA
treatment in wild-type embryos mimics the ca5
cof mutant
phenotype shows that zebrafish can be used as an easy and
inexpensive in vivo model for screening and validating the
functionality of novel CA5 modulators as potential therapeutics
for a variety of diseases.
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